Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains

Neurobiology of Aging

Volumn 17, Issue 2, 1996, Pages 249-257

  Tekirian, Tina L ^a   Cole, Gregory M ^b   Russell, Michael J ^c   Yang, Fushen ^b   Wekstein, David R ^a   Patel, Ela ^a   Snowdon, David A ^a   Markesbery, William R ^a   Geddes, James W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dogs; Humans; Polar bears; Amyloid

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAR; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DOG; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0029978976     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(95)02062-4     Document Type: Article

References (53)

1. Abraham, C. R.; Selkoe, D. J.; Potter, H. Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501; 1988.
2. Allsop, D.; Haga, S. I.; Haga, C.; Ikeda, S. I.; Mann, D. M.; Ishii, T. Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol. Appl. Neurobiol. 15:531-542; 1989.
3. Ball, M. J.; MacGregor, J.; Fyfe, I. M.; Rapoport, S. I.; London, E. D. Paucity of morphological changes in the brains of ageing beagle dogs: Further evidence that Alzheimer lesions are unique for primate central nervous system. Neurobiol. Aging. 4:127-131; 1983.
4. Braak, H.; Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82:239-259; 1991.
5. Burdick, D.; Soreghan, B.; Kwon, M.; Kosmoski, J.; Knauer, M.; Henschen, A.; Yates, J.; Cotman, C.; Glabe, C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:546-554; 1992.
6. Conn, K. J.; Papastoitsis, G.; Meckelein, B.; Abraham, C. R. Identification of full length β-amyloid precursor protein in human neuronal and nonneuronal cell culture supernatant: A possible extracellular source for the generation of Aβ. Amyloid: Int. J. Clin. Invest. 1:232-239; 1994.
7. Cork, L. C.; Powers, R. E.; Selkoe, D. I.; Davies, P.; Geyer, J. J.; Price, D. L. Neurofibrillary tangles and senile plaques in aged bears. J. Neuropathol. Exp. Neurol. 47:629-641; 1988.
8. Cummings, B. J.; Su, J. H.; Cotman, C. W.; White, R.; Russell, M. J. Beta-amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14:547-560; 1993.
9. Dickson, D. W.; Crystal, H. A.; Mattiace, L. A.; Masur, D. M.; Blau, A. D.; Davies, P.; Yen, S. H.; Aronson, M. K. Identification of normal and pathologic aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13:179-189; 1992.
10. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F.; Guido, T.; Hagopian, S.; Johnson-Wood, K.; Khan, K.; Lee, M.; Leibowitz, P.; Liebergurg, I.; Little, S.; Masliah, E.; McConlogue, L.; Montoya-Azvala, M.; Mucke, L.; Paganini, L.; Penniman, E.; Power, M.; Schenk, D.; Seubert, P.; Snyder, B.; Soriano, F.; Tan, H.; Vitale, J.; Wadsworth, S.; Wolozin, B.; Zhao, J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527; 1995.
11. Giaccone, G.; Verga, L.; Finazzi, M.; Polio, B.; Tagliavini, F.; Frangione, B.; Bugiani, O. Cerebral preamyloid deposits and congophilic angiopathy in aged dogs. Neurosci. Lett. 114:178-183; 1990.
12. Greenberg, S. G.; Davies, P.; Schein, J. D.; Binder, L. I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:564-569; 1992.
13. Iwatsubo, T.; Mann, D. M. A.; Odaka, A.; Suzuki, N.; Ihara, Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37:294-299; 1995.
14. Iwatsubo, T.; Odaka, A.; Suzuki, N.; Mizusawa, H.; Nukina, N.; Ihara, Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13:45-64; 1994.
15. Jarrett, J. T.; Berger, E. P.; Lansbury, P. T. J. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697; 1993.
16. Johnstone, E. M.; Chaney, M. O.; Norris, F. H.; Pascual, R.; Little, S. P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res. Mol. Brain Res. 10:299-305; 1991.
17. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1105; 1985.
18. Kida, E.; Golabek, A. A.; Wisniewski, T.; Wisniewski, K. E. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci. Lett. 167:73-76; 1994.
19. Kitamoto, T.; Ogomori, K.; Tateishi, J.; Prusiner, S. B. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57:230-236; 1987.
20. Mak, K.; Yang, F.; Vinters, H. V.; Frautschy, S. A.; Cole, G. M. Polyclonals to β-amyloid (1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res. 667:138-142; 1994.
21. Mandybur, T. I. The incidence of cerebral amyloid angiopathy in Alzheimer's disease. Neurology 25:120; 1975.
22. Mann, D. M.; Brown, A.; Prinja, D.; Davies, C. A.; Landon, M.; Masters, C. L.; Beyreuther, K. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol. Appl. Neurobiol. 15:317-329; 1989.
23. Martin, L. J.; Pardo, C. A.; Cork, L. C.; Price, D. L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145:1358-1381; 1994.
24. Miller, D. L.; Papayannopoulos, I. A.; Styles, J.; Bobin, S. A.; Lin, Y. Y.; Biemann, K.; Iqbal, K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301:41-52; 1993.
25. Mori, H.; Takio, K.; Ogawara, M.; Selkoe, D. J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267:17082-17086; 1992.
26. Namba, Y.; Tomonaga, M.; Kawasaki, H.; Otomo, E.; Ikeda, K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166; 1991.
27. Näslund, J.; Schierhorn, A.; Hellman, U.; Lannfelt, L.; Roses, A. D.; Tjernberg, L. O.; Silberring, J.; Gandy, S. E.; Winblad, B.; Greengard, P.; Norstedt, C.; Terenius, L. Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc. Natl. Acad. Sci. USA 91:8378-8382; 1994.
28. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
29. Pike, C. J.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207:367-368; 1991.
30. Poduri, A.; Gearing, M.; Rebeck, G. W.; Mirra, S. S.; Tigges, J.; Hyman, B. T. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am. J. Pathol. 144: 1183-1187; 1994.
31. Roher, A. E.; Lowenson, J. D.; Clarke, S.; Wolkow, C.; Wang, R.; Cotter, R. J.; Reardon, I. M.; Zürcher-Neely, H. A.; Heinrikson, R. L.; Ball, M. J.; Greenberg, B. D. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268:3072-3083; 1993.
32. Rozemuller, H. M.; Eikelenboom, P.; Stam, F. C.; Beyreuther, K.; Masters, C. L. A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid depostion. J. Neuropathol. Exp. Neurol. 48:674-691; 1989.
33. Russell, M. J.; White, R.; Patel, E.; Markesbery, W. R.; Watson, C. R.; Geddes, J. W. Familial influence on plaque formation in the beagle brain. Neuroreport 3:1093-1096; 1992.
34. Saido, T. C.; Iwatsubo, T.; Mann, D. M. A.; Shimada, H.; Ihara, Y.; Kawashima, S. Dominant and differential deposition of distinct β-amyloid species, AβN3(pE), in senile plaques. Neuron 14:457-486; 1995.
35. Selkoe, D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17:489-517; 1994.
36. Selkoe, D. J.; Bell, D. S.; Podlisny, M. B.; Price, D. L.; Cork, L. C. Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235:873-877; 1987.
37. Seubert, P.; Vigo, P. C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327; 1992.
38. Shimada, A.; Kuwamura, M.; Awakura, T.; Umemura, T.; Takada, K.; Ohama, E.; Itakura, C. Topographic relationship between senile plaques and cerebrovascular amyloidosis in the brain of aged dogs. J. Vet. Med. Sci. 54:137-144; 1992.
39. Shimada, A.; Kuwamura, M.; Umemura, T.; Takada, K.; Ohama, E.; Itakura, C. Modified Bielschowsky and immunohistochemical studies on senile plaques in aged dogs. Neurosci. Lett. 129:25-38; 1991.
40. Snow, A. D.; Mar, H.; Nochlin, D.; Kimata, K.; Kato, M.; Suzuki, S.; Hassell, J.; Wight, T. N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:456-463; 1988.
41. Soto, C.; Branes, M. C.; Alvarez, J.; Inestrosa, N. C. Structural determinants of the Alzheimer's amyloid beta-peptide. J. Neurochem. 63:1191-1198; 1994.
42. Strittmatter, W. J.; Saunders, A. M.; Schechel, D.; Pericak-Vance, M.; Enghild, J.; Salvesen, G. S.; Roses, A. D. Apoliprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-1981; 1993.
43. Suzuki, N.; Cheung, T. T.; Cai, X. D.; Odaka, A.; Otvos, L. J.; Eckman, C.; Golde, T. E.; Younkin, S. G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264:1336-1340; 1994.
44. Tomlinson, B. E.; Blessed, G.; Roth, M. Observations on the brains of nondemented old people. J. Neurol Sci. 7:331-356; 1968.
45. Uéda, K.; Fukushima, H.; Masliah, E.; Xia, Y.; Iwai, A.; Yoshimoto, M.; Otero, D. A. C.; Kondo, J.; Ihara, Y.; Saitoh, T. Molecular cloning of a novel component of amyloid in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90:11282-11286; 1993.
46. Van Hoesen, G. W.; Hyman, B. T. Hippocampal formation: Anatomy and the patterns of pathology in Alzheimer's disease. In: Storm-Mathisen, J.; Zimmer, J; Ottersen, O. P., eds. Progress in brain research. New York: Elsevier; 1990.
47. Vinters, H. V. Cerebral amyloid angiopathy and Alzheimer's disease: Two entities or one? J. Neurol Sci. 112:1-3; 1992.
48. Walker, L. C.; Price, D. L.; Voytko, M. L.; Schenk, D. B. Labeling of cerebral amyloid in vivo with a monoclonal antibody. J. Neuropathol. Exp. Neurol. 53:377-383; 1994.
49. Wisniewski, H.; Johnson, A. B.; Raine, C. S.; Kay, W. J.; Terry, R. D. Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab. Invest. 23:287-296; 1970.
50. Wisniewski, H. M.; Terry, M. D. Reexamination of the pathogenesis of the senile plaque. In: Zimmerman, H. M., ed. Progress in Neuropathology. New York, NY: Grune & Stratton, Inc; 1973;1-26.
51. Yamamoto, T.; Hirano, A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol. Appl. Neurobiol. 12:3-9; 1986.
52. Yang, F.; Mak, K.; Vinters, H. V.; Frautschy, S. A.; Cole, G. M. Monoclonal antibody to the C-terminus of β-amyloid. Neuroreport 5:2117-2120; 1994.
53. Younkin, S. G. Evidence that Aβ42 is the real culprit in Alzheimer's Disease. Ann. Neurol. 37:287-288; 1995.